A survey of people who have taken part in clinical trials indicates that participants care more about the benefits to science than the risk of sharing their personal data.
New research suggests future antiviral drugs could take advantage of viperin, a naturally occurring enzyme in humans and other mammals that has antiviral effects on a wide variety of viruses, including West Nile, hepatitis C, rabies, and HIV.
A mechanism enabling cells to bind and isolate toxic substances could have significant implications for how tumours develop resistance to certain types of chemotherapy.
Commonly believed to be genetic parasites, recent work suggests that at least some transposable elements might be critical for the organism.
Researchers have developed a new method for correcting the errors that creep into DNA barcodes, yielding far more accurate results and paving the way for more ambitious medical research in the future.
Scientists have produced pigs that can resist one of the world’s most costly animal diseases, by changing their genetic code. And the animals show no signs that the change in their DNA has had any other impact on their health or wellbeing — yet.
Using artificial intelligence, digital therapeutics, and genomics, these are the top five startups that are disrupting U.S. healthcare today.
To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
Competition to be the leader in the HIV treatment market is heating up as GSK announces they will be showcasing results for their new therapy at the International AIDS Conference next month.
The development of an aggressive, early-onset form of colon cancer may come down to a single missing iron atom in a key DNA repair protein, according to new research.
We’d all dearly like to see a cure for the common cold, but it never quite seems to arrive. So what’s the hold-up — and will it be over soon? Getting rid of this scourge is nothing to be sneezed at.
The U.S. Patent and Trademark Office has decided to grant not just one, but two new CRISPR patents to UC Berkeley, home of pioneer Jennifer Doudna, who many consider the creator of the technology.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
Experimental malaria vaccines, which independently achieve 48% and 68% reductions in malaria cases can achieve 91% reduction when combined, according to new research.
Travel allows us to see the world – and bring foreign diseases home. Here’s why spreading disease is easier than ever.